Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Agios Pharmaceuticals, Inc. | StockGist | StockGist

Companies
AGIO
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings AGIOSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Agios Pharmaceuticals, Inc.

Filed Mar 26, 2026

Accepted Mar 26, 2026, 3:12 PM ET

CIK 0001439222

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

AGIOS PHARMACEUTICALS, INC.

Person Type

IA

Amendment History

2 filings

SCHEDULE 13G
Original
Feb 17, 20260001172661-26-001266
SCHEDULE 13G/A
Amendment 1
Latest
Viewing
Mar 26, 20260000102909-26-000536

Recent Filings

Agios Pharmaceuticals, Inc.1 months ago

Agios Pharmaceuticals, Inc.1 months ago

Agios Pharmaceuticals, Inc.1 months ago

Agios Pharmaceuticals, Inc.1 months ago

Agios Pharmaceuticals, Inc.1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice